Re-evaluating disease-free survival (DFS) as an endpoint versus overall survival (OS) in adjuvant colon cancer (CC) trials with chemotherapy + /- biologics: An updated surrogacy analysis based on 18,886 patients (pts) from the Accent database Meeting Abstract
| Authors: | Shi, Q.; De Gramont, A.; Dixon, J. G.; Yin, J.; Van Cutsem, E.; Taieb, J.; Alberts, S. R.; Wolmark, N.; Schmoll, H. J.; Saltz, L. B.; Goldberg, R. M.; Kerr, R.; Lonardi, S.; Yoshino, T.; Yothers, G.; Grothey, A.; Andre, T.; Salem, M. E. |
| Abstract Title: | Re-evaluating disease-free survival (DFS) as an endpoint versus overall survival (OS) in adjuvant colon cancer (CC) trials with chemotherapy + /- biologics: An updated surrogacy analysis based on 18,886 patients (pts) from the Accent database |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 191s |
| Language: | English |
| ACCESSION: | WOS:000487345805082 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.3502 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 3502 -- Source: Wos |
